Kite Medical Hub

SCROLL

Bitesize education

Explore expert insights and educational material on CAR T-cell therapy and access up-to-date information on NHL. The Kite Medical Hub is a non-promotional website intended for healthcare professionals in the UK and Ireland, designed, built and funded by Kite, a Gilead Company.

eRMM Tool

Welcome to eRMM Tool an interactive training tool on the management of cytokine release syndrome and neurotoxicity in your YESCARTA^® (axicabtagene ciloleucel) CAR T patients.

A CAR T patient avatar will take you on their treatment journey: from preparing your delivery centre, handling and administering treatment to managing any side effects promptly.

Upon completing a quiz at the end, you will be awarded an accredited CPD Certificate.

>>CLICK HERE

Additional monitoring required.

Adverse events should be reported. For the UK, reporting forms and information can be found at https://yellowcard.mhra.gov.uk/or via the Yellow Card app (download from the Apple App Store or Google Play Store). Adverse events should also be reported to Gilead at safety_FC@gilead.com or +44 (0) 1223 897500.

Adverse events should be reported. For Ireland, reporting forms and information can be found at www.hpra.ie and can be reported to HPRA on +353 1 6764971. Adverse events should also be reported to Gilead at safety_FC@gilead.com or +44 (0) 1223 897500.

Latest podcast

See more podcasts

29 Jul 2021

(DURATION: 24:38 - 23 MB)

Autologous stem cell transplantation: Selecting patients and managing risk

Dr Keith Wilson, Consultant Haematologist at Cardiff and Vale University Health Board, discusses how patients with diffuse large B-cell lymphoma are selected for autologous stem cell transplantation and how they are managed thereafter, including the importance of considering CAR T as a 3rd-line therapy at an early stage.

UK-UNB-1117
December 2021

Play podcast

Latest events

See more events

06 Oct 2021

GIO-Med hybrid event 2021

Explore highlights from the 2021 Gilead Immuno-Oncology Medical Education (GIO-Med) hybrid event, first broadcast as a live event, and now available as a series of on-demand videos.

View event

Abbreviations:
CAR T, chimeric antigen receptor T-cell; GIO-Med, Gilead Immuno-Oncology Medical Education; NHL, non-Hodgkin lymphoma; UK, United Kingdom.